211 related articles for article (PubMed ID: 26859414)
1. Inverse Relationship between Progesterone Receptor and Myc in Endometrial Cancer.
Kavlashvili T; Jia Y; Dai D; Meng X; Thiel KW; Leslie KK; Yang S
PLoS One; 2016; 11(2):e0148912. PubMed ID: 26859414
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic modification restores functional PR expression in endometrial cancer cells.
Yang S; Xiao X; Jia Y; Liu X; Zhang Y; Wang X; Winters CJ; Devor EJ; Meng X; Thiel KW; Leslie KK
Curr Pharm Des; 2014; 20(11):1874-80. PubMed ID: 23888956
[TBL] [Abstract][Full Text] [Related]
3. Panobinostat Enhances Growth Suppressive Effects of Progestin on Endometrial Carcinoma by Increasing Progesterone Receptor and Mitogen-Inducible Gene-6.
Ando H; Miyamoto T; Kashima H; Higuchi S; Ida K; Mvunta DH; Shiozawa T
Horm Cancer; 2017 Aug; 8(4):257-267. PubMed ID: 28516379
[TBL] [Abstract][Full Text] [Related]
4. Systematic dissection of the mechanisms underlying progesterone receptor downregulation in endometrial cancer.
Yang S; Jia Y; Liu X; Winters C; Wang X; Zhang Y; Devor EJ; Hovey AM; Reyes HD; Xiao X; Xu Y; Dai D; Meng X; Thiel KW; Domann FE; Leslie KK
Oncotarget; 2014 Oct; 5(20):9783-97. PubMed ID: 25229191
[TBL] [Abstract][Full Text] [Related]
5. Estrogen receptor alpha mediates progestin-induced mammary tumor growth by interacting with progesterone receptors at the cyclin D1/MYC promoters.
Giulianelli S; Vaqué JP; Soldati R; Wargon V; Vanzulli SI; Martins R; Zeitlin E; Molinolo AA; Helguero LA; Lamb CA; Gutkind JS; Lanari C
Cancer Res; 2012 May; 72(9):2416-27. PubMed ID: 22396492
[TBL] [Abstract][Full Text] [Related]
6. Molecular profiling of estrogen receptor α and progesterone receptor transcript variants in endometrial cancer.
Skrzypczak M; Merx I; Schüler-Toprak S; Weber F; Inwald EC; Ortmann O; Treeck O
Steroids; 2015 Dec; 104():122-8. PubMed ID: 26428028
[TBL] [Abstract][Full Text] [Related]
7. FGF2 induces breast cancer growth through ligand-independent activation and recruitment of ERα and PRBΔ4 isoform to MYC regulatory sequences.
Giulianelli S; Riggio M; Guillardoy T; Pérez Piñero C; Gorostiaga MA; Sequeira G; Pataccini G; Abascal MF; Toledo MF; Jacobsen BM; Guerreiro AC; Barros A; Novaro V; Monteiro FL; Amado F; Gass H; Abba M; Helguero LA; Lanari C
Int J Cancer; 2019 Oct; 145(7):1874-1888. PubMed ID: 30843188
[TBL] [Abstract][Full Text] [Related]
8. Chromatin composition alterations and the critical role of MeCP2 for epigenetic silencing of progesterone receptor-B gene in endometrial cancers.
Chu Y; Wang Y; Zhang G; Chen H; Dowdy SC; Xiong Y; Liu F; Zhang R; Li J; Jiang SW
Cell Mol Life Sci; 2014 Sep; 71(17):3393-408. PubMed ID: 24531693
[TBL] [Abstract][Full Text] [Related]
9. Eliminating epigenetic barriers induces transient hormone-regulated gene expression in estrogen receptor negative breast cancer cells.
Fleury L; Gerus M; Lavigne AC; Richard-Foy H; Bystricky K
Oncogene; 2008 Jul; 27(29):4075-85. PubMed ID: 18317449
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic-mediated upregulation of progesterone receptor B gene in endometrial cancer cell lines.
Xiong Y; Dowdy SC; Gonzalez Bosquet J; Zhao Y; Eberhardt NL; Podratz KC; Jiang SW
Gynecol Oncol; 2005 Oct; 99(1):135-41. PubMed ID: 16024066
[TBL] [Abstract][Full Text] [Related]
11. Kruppel-like factor 9 is a negative regulator of ligand-dependent estrogen receptor alpha signaling in Ishikawa endometrial adenocarcinoma cells.
Velarde MC; Zeng Z; McQuown JR; Simmen FA; Simmen RC
Mol Endocrinol; 2007 Dec; 21(12):2988-3001. PubMed ID: 17717078
[TBL] [Abstract][Full Text] [Related]
12. Development of a technique to detect the activated form of the progesterone receptor and correlation with clinical and histopathological characteristics of endometrioid adenocarcinoma of the uterine corpus.
Bonneterre J; Hutt E; Bosq J; Graham JD; Powell MA; Leblanc E; Fujiwara K; Herzog TJ; Coleman RL; Clarke CL; Gilles EM; Zukiwski AA; Monk BJ
Gynecol Oncol; 2015 Sep; 138(3):663-7. PubMed ID: 26142884
[TBL] [Abstract][Full Text] [Related]
13. Progesterone induces progesterone receptor gene (PGR) expression via rapid activation of protein kinase pathways required for cooperative estrogen receptor alpha (ER) and progesterone receptor (PR) genomic action at ER/PR target genes.
Diep CH; Ahrendt H; Lange CA
Steroids; 2016 Oct; 114():48-58. PubMed ID: 27641443
[TBL] [Abstract][Full Text] [Related]
14. Molecular tools to reestablish progestin control of endometrial cancer cell proliferation.
Dai D; Kumar NS; Wolf DM; Leslie KK
Am J Obstet Gynecol; 2001 Apr; 184(5):790-7. PubMed ID: 11303185
[TBL] [Abstract][Full Text] [Related]
15. Chromatin topology defines estradiol-primed progesterone receptor and PAX2 binding in endometrial cancer cells.
La Greca A; Bellora N; Le Dily F; Jara R; Nacht AS; Quilez Oliete J; Villanueva JL; Vidal E; Merino G; Fresno C; Tarifa Reischle I; Vallejo G; Vicent G; Fernández E; Beato M; Saragüeta P
Elife; 2022 Jan; 11():. PubMed ID: 35018885
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the functional progesterone receptor in an endometrial adenocarcinoma cell line (Ishikawa): progesterone-induced expression of the alpha1 integrin.
Lessey BA; Ilesanmi AO; Castelbaum AJ; Yuan L; Somkuti SG; Chwalisz K; Satyaswaroop PG
J Steroid Biochem Mol Biol; 1996 Sep; 59(1):31-9. PubMed ID: 9009235
[TBL] [Abstract][Full Text] [Related]
17. Enhancing progestin therapy via HDAC inhibitors in endometrial cancer.
Li Y; Zhou W; Li L; Li JW; Li T; Huang C; Lazaro-Camp VJ; Kavlashvili T; Zhang Y; Reyes H; Li Y; Dai D; Zhu W; Meng X; Leslie KK; Yang S
Am J Cancer Res; 2022; 12(11):5029-5048. PubMed ID: 36504895
[TBL] [Abstract][Full Text] [Related]
18. Loss of progesterone receptor through epigenetic regulation is associated with poor prognosis in solid tumors.
Li Y; Huang C; Kavlashvili T; Fronk A; Zhang Y; Wei Y; Dai D; Devor EJ; Meng X; Thiel KW; Leslie KK; Yang S
Am J Cancer Res; 2020; 10(6):1827-1843. PubMed ID: 32642294
[TBL] [Abstract][Full Text] [Related]
19. The Application of Non-Invasive Apoptosis Detection Sensor (NIADS) on Histone Deacetylation Inhibitor (HDACi)-Induced Breast Cancer Cell Death.
Hsu KW; Huang CY; Tam KW; Lin CY; Huang LC; Lin CL; Hsieh WS; Chi WM; Chang YJ; Wei PL; Chen ST; Lee CH
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29393914
[TBL] [Abstract][Full Text] [Related]
20. Role of steroid receptor-associated and regulated protein in tumor progression and progesterone receptor signaling in endometrial cancer.
Liu J; Wang Z; Zhou J; Wang J; He X; Wang J
Chin Med J (Engl); 2023 Nov; 136(21):2576-2586. PubMed ID: 37144734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
